{"id": "66", "iri": "66", "baseIri": "66", "instances": "66", "attributes": "66", "label_IRI-based": "ND_0001100", "label_undefined": "diagnostic guideline", "annotations": {"curator note": [{"identifier": "IAO_0000232", "language": "undefined", "value": "This class belongs in the domain of OGMS, will be a subtype of IAO_0000033:'directive information entity'. Refer to:\n\nhttp://code.google.com/p/ogms/wiki/DiagnosisGuideline\n\nhttp://code.google.com/p/ogms/issues/detail?id=75\n\nhttps://groups.google.com/forum/?fromgroups=#!topic/ogms-discuss/9oVK5dLdZQs", "type": "label"}], "definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "A directive information entity the concretization of which is realized in a diagnostic process and which has a set of diagnostic criteria that consist of clinical findings that have been agreed upon by the medical community to provide sufficient, necessary, or sufficient and necessary warrant for a clinician to reach a particular diagnosis concerning a patient whose clinical picture satisfies the relevant diagnostic criteria.  A diagnostic guideline has as parts the objective of accurately diagnosing patients according to its diagnostic criteria and the directive for the clinician to make the associated diagnosis when the diagnostic criteria have been determined to be satisfied.\n\nAlexander P. Cox", "type": "label"}, {"identifier": "IAO_0000115", "language": "undefined", "value": "A directive information entity that specifies how to establish a diagnosis according to one or more clinical findings, the concretization of which is realized in a diagnostic process.\n\nMark Jensen", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["12"], "subClasses": ["1334", "1296", "1298"], "name": "diagnostic guideline", "body": "A directive information entity that specifies how to establish a diagnosis according to one or more clinical findings, the concretization of which is realized in a diagnostic process.\n\nMark Jensen\n\nA directive information entity the concretization of which is realized in a diagnostic process and which has a set of diagnostic criteria that consist of clinical findings that have been agreed upon by the medical community to provide sufficient, necessary, or sufficient and necessary warrant for a clinician to reach a particular diagnosis concerning a patient whose clinical picture satisfies the relevant diagnostic criteria.  A diagnostic guideline has as parts the objective of accurately diagnosing patients according to its diagnostic criteria and the directive for the clinician to make the associated diagnosis when the diagnostic criteria have been determined to be satisfied.\n\nAlexander P. Cox", "children": [{"id": "1296", "iri": "1296", "baseIri": "1296", "instances": "1296", "attributes": "1296", "label_IRI-based": "ND_0001101", "label_undefined": "diagnostic guideline for mild cognitive impairment", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "*** REVISE ***\n\nCognitive impairments beyond those expected based on the age and education of the individual, but which are not significant enough to interfere with their daily activities.\n\nThe diagnosis of MCI requires considerable clinical judgement as well as a comprehensive clinical assessment including clinical observation, neuroimaging, blood tests and neuropsychological testing in order to rule out an alternate diagnosis.\n\nMCI is diagnosed when there is:\n\n1. Evidence of memory impairment\n2. Preservation of general cognitive and functional abilities\n3. Absence of diagnosed dementia", "type": "label"}, {"identifier": "IAO_0000115", "language": "undefined", "value": "Memory complaint, preferably corroborated by an informant\nObjective memory impairment (below 1.5 standard deviations)\nNormal general cognitive functioning\nIntact activities of daily living\nNot demented", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "Adapted from: http://en.wikipedia.org/wiki/Mild_cognitive_impairment", "type": "label"}, {"identifier": "IAO_0000119", "language": "undefined", "value": "http://www.mejfm.com/journal/Oct2004/Dementia.htm", "type": "label"}]}, "superClasses": ["66"], "subClasses": ["1329"], "name": "diagnostic guideline for mild cognitive impairment", "body": "Memory complaint, preferably corroborated by an informant\nObjective memory impairment (below 1.5 standard deviations)\nNormal general cognitive functioning\nIntact activities of daily living\nNot demented\n\n*** REVISE ***\n\nCognitive impairments beyond those expected based on the age and education of the individual, but which are not significant enough to interfere with their daily activities.\n\nThe diagnosis of MCI requires considerable clinical judgement as well as a comprehensive clinical assessment including clinical observation, neuroimaging, blood tests and neuropsychological testing in order to rule out an alternate diagnosis.\n\nMCI is diagnosed when there is:\n\n1. Evidence of memory impairment\n2. Preservation of general cognitive and functional abilities\n3. Absence of diagnosed dementia", "children": [{"id": "1329", "iri": "1329", "baseIri": "1329", "instances": "1329", "attributes": "1329", "label_IRI-based": "ND_0001102", "label_undefined": "diagnostic guideline for dementia", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "*** REVISE ***\n\nA diagnosis of dementia in a patient based on findings from blood tests, neuroimaging, and cognitive testing that indicate the presence of cognitive deficits [visual spatial, attention, orientation, exceutive function, functional] severe enough to interfere with the patient's daily life in a previously unimpaired person.", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1296"], "subClasses": ["15", "1318", "1321"], "name": "diagnostic guideline for dementia", "body": "*** REVISE ***\n\nA diagnosis of dementia in a patient based on findings from blood tests, neuroimaging, and cognitive testing that indicate the presence of cognitive deficits [visual spatial, attention, orientation, exceutive function, functional] severe enough to interfere with the patient's daily life in a previously unimpaired person.", "children": [{"id": "1321", "iri": "1321", "baseIri": "1321", "instances": "1321", "attributes": "1321", "label_IRI-based": "ND_0001103", "label_undefined": "diagnostic guideline for infectious dementia", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1329"], "subClasses": ["1320", "1323", "1325", "1327"], "name": "diagnostic guideline for infectious dementia", "body": "", "children": [{"id": "1320", "iri": "1320", "baseIri": "1320", "instances": "1320", "attributes": "1320", "label_IRI-based": "ND_0001108", "label_undefined": "diagnostic guideline for infectious dementia due to prion disease", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1321"], "subClasses": null, "name": "diagnostic guideline for infectious dementia due to prion disease", "body": ""}, {"id": "1323", "iri": "1323", "baseIri": "1323", "instances": "1323", "attributes": "1323", "label_IRI-based": "ND_0001107", "label_undefined": "diagnostic guideline for infectious dementia due to syphilis", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1321"], "subClasses": null, "name": "diagnostic guideline for infectious dementia due to syphilis", "body": ""}, {"id": "1325", "iri": "1325", "baseIri": "1325", "instances": "1325", "attributes": "1325", "label_IRI-based": "ND_0001106", "label_undefined": "diagnostic guideline for infectious dementia due to HIV", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1321"], "subClasses": null, "name": "diagnostic guideline for infectious dementia due to HIV", "body": ""}, {"id": "1327", "iri": "1327", "baseIri": "1327", "instances": "1327", "attributes": "1327", "label_IRI-based": "ND_0001109", "label_undefined": "diagnostic guideline for infectious dementia due to Creutzfeldt-Jakob disease", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1321"], "subClasses": null, "name": "diagnostic guideline for infectious dementia due to Creutzfeldt-Jakob disease", "body": ""}]}, {"id": "15", "iri": "15", "baseIri": "15", "instances": "15", "attributes": "15", "label_IRI-based": "ND_0001105", "label_undefined": "diagnostic guideline for neurodegenerative dementia", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1329"], "subClasses": ["14", "21", "28", "1336", "1338", "1340", "1342", "1344", "1346", "1150", "1154", "1158", "1163"], "name": "diagnostic guideline for neurodegenerative dementia", "body": "", "children": [{"id": "14", "iri": "14", "baseIri": "14", "instances": "14", "attributes": "14", "label_IRI-based": "ND_0001119", "label_undefined": "diagnostic guideline for possible dementia with Lewy bodies", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "Dementia plus one of the following: fluctuation, visual hallucination, parkinsonism, REM sleep behavioral disorder.", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1301"], "name": "diagnostic guideline for possible dementia with Lewy bodies", "body": "Dementia plus one of the following: fluctuation, visual hallucination, parkinsonism, REM sleep behavioral disorder.", "children": [{"id": "1301", "iri": "1301", "baseIri": "1301", "instances": "1301", "attributes": "1301", "label_IRI-based": "ND_0001120", "label_undefined": "diagnostic guideline for probable dementia with Lewy bodies", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "Dementia plus two or more of the following: fluctuation, visual hallucination, parkinsonism, REM sleep behavioral disorder.", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["14"], "subClasses": ["1428"], "name": "diagnostic guideline for probable dementia with Lewy bodies", "body": "Dementia plus two or more of the following: fluctuation, visual hallucination, parkinsonism, REM sleep behavioral disorder.", "children": [{"id": "1428", "iri": "1428", "baseIri": "1428", "instances": "1428", "attributes": "1428", "label_IRI-based": "ND_0001121", "label_undefined": "diagnostic guideline for definite dementia with Lewy bodies", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1301"], "subClasses": null, "name": "diagnostic guideline for definite dementia with Lewy bodies", "body": ""}]}]}, {"id": "21", "iri": "21", "baseIri": "21", "instances": "21", "attributes": "21", "label_IRI-based": "ND_0001116", "label_undefined": "diagnostic guideline for possible frontotemporal dementia", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "*** REVISE ***\n\nInsidious onset, slow progression\nImpaired behavior: \n-loss of personal awareness, Disinhibition, mental rigidity, Hyperorality, Stereotypy, Perseveration, utilization behavior, Distractibility, poor social judgment\nAltered affect:\n-Depression, Anxiety, Delusions, Somatic preoccupations, Apathy, Amimia\nSpeech disorder:\n-Reduced, stereotypic, echolalic, perseveration, mutism\nPhysical signs:\n-Primitive reflexes, Incontinence, Parkinsonism", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1304"], "name": "diagnostic guideline for possible frontotemporal dementia", "body": "*** REVISE ***\n\nInsidious onset, slow progression\nImpaired behavior: \n-loss of personal awareness, Disinhibition, mental rigidity, Hyperorality, Stereotypy, Perseveration, utilization behavior, Distractibility, poor social judgment\nAltered affect:\n-Depression, Anxiety, Delusions, Somatic preoccupations, Apathy, Amimia\nSpeech disorder:\n-Reduced, stereotypic, echolalic, perseveration, mutism\nPhysical signs:\n-Primitive reflexes, Incontinence, Parkinsonism", "children": [{"id": "1304", "iri": "1304", "baseIri": "1304", "instances": "1304", "attributes": "1304", "label_IRI-based": "ND_0001117", "label_undefined": "diagnostic guideline for probable frontotemporal dementia", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["21"], "subClasses": ["1303"], "name": "diagnostic guideline for probable frontotemporal dementia", "body": "", "children": [{"id": "1303", "iri": "1303", "baseIri": "1303", "instances": "1303", "attributes": "1303", "label_IRI-based": "ND_0001118", "label_undefined": "diagnostic guideline for definite frontotemporal dementia", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1304"], "subClasses": null, "name": "diagnostic guideline for definite frontotemporal dementia", "body": ""}]}]}, {"id": "1342", "iri": "1342", "baseIri": "1342", "instances": "1342", "attributes": "1342", "label_IRI-based": "ND_0001124", "label_undefined": "diagnostic guideline for possible frontotemporal dementia with Parkinsonism linked to chromosome 17", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1415"], "name": "diagnostic guideline for possible frontotemporal dementia with Parkinsonism linked to chromosome 17", "body": "", "children": [{"id": "1415", "iri": "1415", "baseIri": "1415", "instances": "1415", "attributes": "1415", "label_IRI-based": "ND_0001129", "label_undefined": "diagnostic guideline for probable frontotemporal dementia with Parkinsonism linked to chromosome 17", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1342"], "subClasses": ["1452"], "name": "diagnostic guideline for probable frontotemporal dementia with Parkinsonism linked to chromosome 17", "body": "", "children": [{"id": "1452", "iri": "1452", "baseIri": "1452", "instances": "1452", "attributes": "1452", "label_IRI-based": "ND_0001134", "label_undefined": "diagnostic guideline for definite frontotemporal dementia with Parkinsonism linked to chromosome 17", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "*** REVISE ***\n\nDefinite diagnosis of FTDP-17 requires a combination of characteristic clinical and pathological features and molecular genetic analysis.", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "http://en.wikipedia.org/wiki/Frontotemporal_dementia_and_parkinsonism_linked_to_chromosome_17", "type": "label"}]}, "superClasses": ["1415"], "subClasses": null, "name": "diagnostic guideline for definite frontotemporal dementia with Parkinsonism linked to chromosome 17", "body": "*** REVISE ***\n\nDefinite diagnosis of FTDP-17 requires a combination of characteristic clinical and pathological features and molecular genetic analysis."}]}]}, {"id": "1344", "iri": "1344", "baseIri": "1344", "instances": "1344", "attributes": "1344", "label_IRI-based": "ND_0001123", "label_undefined": "diagnostic guideline for possible corticobasal degeneration", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "Insidious onset and progression of assymetric cortical and basal ganglionic features. Akinetic, rigid syndrome; hyperkinetic movement disorder; alien limb. Cortical dysfunction: dementia, apraxia, cortical sensory, dysphasia, speech apraxia", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1418"], "name": "diagnostic guideline for possible corticobasal degeneration", "body": "Insidious onset and progression of assymetric cortical and basal ganglionic features. Akinetic, rigid syndrome; hyperkinetic movement disorder; alien limb. Cortical dysfunction: dementia, apraxia, cortical sensory, dysphasia, speech apraxia", "children": [{"id": "1418", "iri": "1418", "baseIri": "1418", "instances": "1418", "attributes": "1418", "label_IRI-based": "ND_0001128", "label_undefined": "diagnostic guideline for probable corticobasal degeneration", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1344"], "subClasses": ["1455"], "name": "diagnostic guideline for probable corticobasal degeneration", "body": "", "children": [{"id": "1455", "iri": "1455", "baseIri": "1455", "instances": "1455", "attributes": "1455", "label_IRI-based": "ND_0001133", "label_undefined": "diagnostic guideline for definite corticobasal degeneration", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1418"], "subClasses": null, "name": "diagnostic guideline for definite corticobasal degeneration", "body": ""}]}]}, {"id": "1346", "iri": "1346", "baseIri": "1346", "instances": "1346", "attributes": "1346", "label_IRI-based": "ND_0001122", "label_undefined": "diagnostic guideline for possible Parkinson dementia", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "Features of dementia associated with Parkinson\u2019s disease:\n\nI. Core features\n\n1. Diagnosis of Parkinson\u2019s disease according to Queen Square Brain Bank criteria \n\n2. A dementia syndrome with insidious onset and slow progression, developing within the context of established Parkinson\u2019s disease and diagnosed by history, clinical, and mental examination, defined as: \n\u2022 Impairment in more than one cognitive domain \n\u2022 Representing a decline from premorbid level \n\u2022 Deficits severe enough to impair daily life (social, occupational, or personal care), independent of the impairment ascribable to motor or autonomic symptoms\n\nII. Associated clinical features\n\n1. Cognitive features:\n\u2022 Attention: Impaired. Impairment in spontaneous and focused attention, poor performance in attentional tasks; performance may fluctuate during the day and from day to day\n\u2022 Executive functions: Impaired. Impairment in tasks requiring initiation, planning, concept formation, rule finding, set shifting or set maintenance; impaired mental speed (bradyphrenia)\n\u2022 Visuo-spatial functions: Impaired. Impairment in tasks requiring visual-spatial orientation, perception, or construction \n\u2022 Memory: Impaired. Impairment in free recall of recent events or in tasks requiring learning new material, memory usually improves with cueing, recognition is usually better than free recall \n\u2022 Language: Core functions largely preserved. Word finding difficulties and impaired comprehension of complex sentences may be present \n\n2. Behavioral features:\n\u2022 Apathy: decreased spontaneity; loss of motivation, interest, and effortful behavior \n\u2022 Changes in personality and mood including depressive features and anxiety \n\u2022 Hallucinations: mostly visual, usually complex, formed visions of people, animals or objects \n\u2022 Delusions: usually paranoid, such as infidelity, or phantom boarder (unwelcome guests living in the home) delusions \n\u2022 Excessive daytime sleepiness\n\nIII. Features which do not exclude PD-D, but make the diagnosis uncertain:\n\n\u2022 Co-existence of any other abnormality which may by itself cause cognitive impairment, but judged not to be the cause of dementia, e.g. presence of relevant vascular disease in imaging\n\u2022 Time interval between the development of motor and cognitive symptoms not known \n\nIV. Features suggesting other conditions or diseases as cause of mental impairment, which, when present make it impossible to reliably diagnose PD-D:\n\n\u2022 Cognitive and behavioral symptoms appearing solely in the context of other conditions such as: Acute confusion due to:\n  a. Systemic diseases or abnormalities\n  b. Drug intoxication Major Depression according to DSM IV\n\u2022 Features compatible with \u201cProbable Vascular dementia\u201d criteria according to NINDS-AIREN (dementia in the context of cerebrovascular disease as indicated by focal signs in neurological exam such as hemiparesis, sensory deficits, and evidence of relevant cerebrovascular disease by brain imaging AND a relationship between the two as indicated by the presence of one or more of the following: onset of dementia within 3 months after a recognized stroke, abrupt deterioration in cognitive functions, and fluctuating, stepwise progression of cognitive deficits)\n\n\nCriteria for the diagnosis of possible PD-D:\n\nA. Core features: Both must be present \n\nB. Associated clinical features:\n\u2022 Atypical profile of cognitive impairment in one or more domains, such as prominent or receptive-type (fluent) aphasia, or pure storage-failure type amnesia (memory does not improve with cueing or in recognition tasks) with preserved attention\n\u2022 Behavioral symptoms may or may not be present OR\n\nC. One or more of the group III features present \n\nD. None of the group IV features present\n\nFrom the article \"Clinical Diagnostic Criteria for Dementia Associated with Parkinson\u2019s Disease\".", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "From the article \"Clinical Diagnostic Criteria for Dementia Associated with Parkinson\u2019s Disease\".\nMovement Disorders\nVol. 22, No. 12, 2007, pp. 1689-1707 \u00a9 2007 Movement Disorder Society", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1425"], "name": "diagnostic guideline for possible Parkinson dementia", "body": "Features of dementia associated with Parkinson\u2019s disease:\n\nI. Core features\n\n1. Diagnosis of Parkinson\u2019s disease according to Queen Square Brain Bank criteria \n\n2. A dementia syndrome with insidious onset and slow progression, developing within the context of established Parkinson\u2019s disease and diagnosed by history, clinical, and mental examination, defined as: \n\u2022 Impairment in more than one cognitive domain \n\u2022 Representing a decline from premorbid level \n\u2022 Deficits severe enough to impair daily life (social, occupational, or personal care), independent of the impairment ascribable to motor or autonomic symptoms\n\nII. Associated clinical features\n\n1. Cognitive features:\n\u2022 Attention: Impaired. Impairment in spontaneous and focused attention, poor performance in attentional tasks; performance may fluctuate during the day and from day to day\n\u2022 Executive functions: Impaired. Impairment in tasks requiring initiation, planning, concept formation, rule finding, set shifting or set maintenance; impaired mental speed (bradyphrenia)\n\u2022 Visuo-spatial functions: Impaired. Impairment in tasks requiring visual-spatial orientation, perception, or construction \n\u2022 Memory: Impaired. Impairment in free recall of recent events or in tasks requiring learning new material, memory usually improves with cueing, recognition is usually better than free recall \n\u2022 Language: Core functions largely preserved. Word finding difficulties and impaired comprehension of complex sentences may be present \n\n2. Behavioral features:\n\u2022 Apathy: decreased spontaneity; loss of motivation, interest, and effortful behavior \n\u2022 Changes in personality and mood including depressive features and anxiety \n\u2022 Hallucinations: mostly visual, usually complex, formed visions of people, animals or objects \n\u2022 Delusions: usually paranoid, such as infidelity, or phantom boarder (unwelcome guests living in the home) delusions \n\u2022 Excessive daytime sleepiness\n\nIII. Features which do not exclude PD-D, but make the diagnosis uncertain:\n\n\u2022 Co-existence of any other abnormality which may by itself cause cognitive impairment, but judged not to be the cause of dementia, e.g. presence of relevant vascular disease in imaging\n\u2022 Time interval between the development of motor and cognitive symptoms not known \n\nIV. Features suggesting other conditions or diseases as cause of mental impairment, which, when present make it impossible to reliably diagnose PD-D:\n\n\u2022 Cognitive and behavioral symptoms appearing solely in the context of other conditions such as: Acute confusion due to:\n  a. Systemic diseases or abnormalities\n  b. Drug intoxication Major Depression according to DSM IV\n\u2022 Features compatible with \u201cProbable Vascular dementia\u201d criteria according to NINDS-AIREN (dementia in the context of cerebrovascular disease as indicated by focal signs in neurological exam such as hemiparesis, sensory deficits, and evidence of relevant cerebrovascular disease by brain imaging AND a relationship between the two as indicated by the presence of one or more of the following: onset of dementia within 3 months after a recognized stroke, abrupt deterioration in cognitive functions, and fluctuating, stepwise progression of cognitive deficits)\n\n\nCriteria for the diagnosis of possible PD-D:\n\nA. Core features: Both must be present \n\nB. Associated clinical features:\n\u2022 Atypical profile of cognitive impairment in one or more domains, such as prominent or receptive-type (fluent) aphasia, or pure storage-failure type amnesia (memory does not improve with cueing or in recognition tasks) with preserved attention\n\u2022 Behavioral symptoms may or may not be present OR\n\nC. One or more of the group III features present \n\nD. None of the group IV features present\n\nFrom the article \"Clinical Diagnostic Criteria for Dementia Associated with Parkinson\u2019s Disease\".", "children": [{"id": "1425", "iri": "1425", "baseIri": "1425", "instances": "1425", "attributes": "1425", "label_IRI-based": "ND_0001127", "label_undefined": "diagnostic guideline for probable Parkinson dementia", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "Features of dementia associated with Parkinson\u2019s disease:\n\nI. Core features\n\n1. Diagnosis of Parkinson\u2019s disease according to Queen Square Brain Bank criteria \n\n2. A dementia syndrome with insidious onset and slow progression, developing within the context of established Parkinson\u2019s disease and diagnosed by history, clinical, and mental examination, defined as: \n\u2022 Impairment in more than one cognitive domain \n\u2022 Representing a decline from premorbid level \n\u2022 Deficits severe enough to impair daily life (social, occupational, or personal care), independent of the impairment ascribable to motor or autonomic symptoms\n\nII. Associated clinical features\n\n1. Cognitive features:\n\u2022 Attention: Impaired. Impairment in spontaneous and focused attention, poor performance in attentional tasks; performance may fluctuate during the day and from day to day\n\u2022 Executive functions: Impaired. Impairment in tasks requiring initiation, planning, concept formation, rule finding, set shifting or set maintenance; impaired mental speed (bradyphrenia)\n\u2022 Visuo-spatial functions: Impaired. Impairment in tasks requiring visual-spatial orientation, perception, or construction \n\u2022 Memory: Impaired. Impairment in free recall of recent events or in tasks requiring learning new material, memory usually improves with cueing, recognition is usually better than free recall \n\u2022 Language: Core functions largely preserved. Word finding difficulties and impaired comprehension of complex sentences may be present \n\n2. Behavioral features:\n\u2022 Apathy: decreased spontaneity; loss of motivation, interest, and effortful behavior \n\u2022 Changes in personality and mood including depressive features and anxiety \n\u2022 Hallucinations: mostly visual, usually complex, formed visions of people, animals or objects \n\u2022 Delusions: usually paranoid, such as infidelity, or phantom boarder (unwelcome guests living in the home) delusions \n\u2022 Excessive daytime sleepiness\n\nIII. Features which do not exclude PD-D, but make the diagnosis uncertain:\n\n\u2022 Co-existence of any other abnormality which may by itself cause cognitive impairment, but judged not to be the cause of dementia, e.g. presence of relevant vascular disease in imaging\n\u2022 Time interval between the development of motor and cognitive symptoms not known \n\nIV. Features suggesting other conditions or diseases as cause of mental impairment, which, when present make it impossible to reliably diagnose PD-D:\n\n\u2022 Cognitive and behavioral symptoms appearing solely in the context of other conditions such as: Acute confusion due to:\n  a. Systemic diseases or abnormalities\n  b. Drug intoxication Major Depression according to DSM IV\n\u2022 Features compatible with \u201cProbable Vascular dementia\u201d criteria according to NINDS-AIREN (dementia in the context of cerebrovascular disease as indicated by focal signs in neurological exam such as hemiparesis, sensory deficits, and evidence of relevant cerebrovascular disease by brain imaging AND a relationship between the two as indicated by the presence of one or more of the following: onset of dementia within 3 months after a recognized stroke, abrupt deterioration in cognitive functions, and fluctuating, stepwise progression of cognitive deficits)\n\n\nCriteria for the diagnosis of probable PD-D:\n\nA. Core features: Both must be present \n\nB. Associated clinical features:\n\u2022 Typical profile of cognitive deficits including impairment in at least two of the four core cognitive domains (impaired attention which may fluctuate, impaired executive functions, impairment in visuo-spatial functions, and impaired free recall memory which usually improves with cueing)\n\u2022 The presence of at least one behavioral symptom (apathy, depressed or anxious mood, hallucinations, delusions, excessive daytime sleepiness) supports the diagnosis of Probable PD-D, lack of behavioral symptoms, however, does not exclude the diagnosis\n\nC. None of the group III features present\n\nD. None of the group IV features present\n\n\n\nFrom the article \"Clinical Diagnostic Criteria for Dementia Associated with Parkinson\u2019s Disease\".", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "From the article \"Clinical Diagnostic Criteria for Dementia Associated with Parkinson\u2019s Disease\".\nMovement Disorders\nVol. 22, No. 12, 2007, pp. 1689-1707 \u00a9 2007 Movement Disorder Society", "type": "label"}]}, "superClasses": ["1346"], "subClasses": ["1458"], "name": "diagnostic guideline for probable Parkinson dementia", "body": "Features of dementia associated with Parkinson\u2019s disease:\n\nI. Core features\n\n1. Diagnosis of Parkinson\u2019s disease according to Queen Square Brain Bank criteria \n\n2. A dementia syndrome with insidious onset and slow progression, developing within the context of established Parkinson\u2019s disease and diagnosed by history, clinical, and mental examination, defined as: \n\u2022 Impairment in more than one cognitive domain \n\u2022 Representing a decline from premorbid level \n\u2022 Deficits severe enough to impair daily life (social, occupational, or personal care), independent of the impairment ascribable to motor or autonomic symptoms\n\nII. Associated clinical features\n\n1. Cognitive features:\n\u2022 Attention: Impaired. Impairment in spontaneous and focused attention, poor performance in attentional tasks; performance may fluctuate during the day and from day to day\n\u2022 Executive functions: Impaired. Impairment in tasks requiring initiation, planning, concept formation, rule finding, set shifting or set maintenance; impaired mental speed (bradyphrenia)\n\u2022 Visuo-spatial functions: Impaired. Impairment in tasks requiring visual-spatial orientation, perception, or construction \n\u2022 Memory: Impaired. Impairment in free recall of recent events or in tasks requiring learning new material, memory usually improves with cueing, recognition is usually better than free recall \n\u2022 Language: Core functions largely preserved. Word finding difficulties and impaired comprehension of complex sentences may be present \n\n2. Behavioral features:\n\u2022 Apathy: decreased spontaneity; loss of motivation, interest, and effortful behavior \n\u2022 Changes in personality and mood including depressive features and anxiety \n\u2022 Hallucinations: mostly visual, usually complex, formed visions of people, animals or objects \n\u2022 Delusions: usually paranoid, such as infidelity, or phantom boarder (unwelcome guests living in the home) delusions \n\u2022 Excessive daytime sleepiness\n\nIII. Features which do not exclude PD-D, but make the diagnosis uncertain:\n\n\u2022 Co-existence of any other abnormality which may by itself cause cognitive impairment, but judged not to be the cause of dementia, e.g. presence of relevant vascular disease in imaging\n\u2022 Time interval between the development of motor and cognitive symptoms not known \n\nIV. Features suggesting other conditions or diseases as cause of mental impairment, which, when present make it impossible to reliably diagnose PD-D:\n\n\u2022 Cognitive and behavioral symptoms appearing solely in the context of other conditions such as: Acute confusion due to:\n  a. Systemic diseases or abnormalities\n  b. Drug intoxication Major Depression according to DSM IV\n\u2022 Features compatible with \u201cProbable Vascular dementia\u201d criteria according to NINDS-AIREN (dementia in the context of cerebrovascular disease as indicated by focal signs in neurological exam such as hemiparesis, sensory deficits, and evidence of relevant cerebrovascular disease by brain imaging AND a relationship between the two as indicated by the presence of one or more of the following: onset of dementia within 3 months after a recognized stroke, abrupt deterioration in cognitive functions, and fluctuating, stepwise progression of cognitive deficits)\n\n\nCriteria for the diagnosis of probable PD-D:\n\nA. Core features: Both must be present \n\nB. Associated clinical features:\n\u2022 Typical profile of cognitive deficits including impairment in at least two of the four core cognitive domains (impaired attention which may fluctuate, impaired executive functions, impairment in visuo-spatial functions, and impaired free recall memory which usually improves with cueing)\n\u2022 The presence of at least one behavioral symptom (apathy, depressed or anxious mood, hallucinations, delusions, excessive daytime sleepiness) supports the diagnosis of Probable PD-D, lack of behavioral symptoms, however, does not exclude the diagnosis\n\nC. None of the group III features present\n\nD. None of the group IV features present\n\n\n\nFrom the article \"Clinical Diagnostic Criteria for Dementia Associated with Parkinson\u2019s Disease\".", "children": [{"id": "1458", "iri": "1458", "baseIri": "1458", "instances": "1458", "attributes": "1458", "label_IRI-based": "ND_0001132", "label_undefined": "diagnostic guideline for definite Parkinson dementia", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1425"], "subClasses": null, "name": "diagnostic guideline for definite Parkinson dementia", "body": ""}]}]}, {"id": "1336", "iri": "1336", "baseIri": "1336", "instances": "1336", "attributes": "1336", "label_IRI-based": "ND_0001126", "label_undefined": "diagnostic guideline for possible progressive supranuclear palsy", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1399"], "name": "diagnostic guideline for possible progressive supranuclear palsy", "body": "", "children": [{"id": "1399", "iri": "1399", "baseIri": "1399", "instances": "1399", "attributes": "1399", "label_IRI-based": "ND_0001131", "label_undefined": "diagnostic guideline for probable progressive supranuclear palsy", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1336"], "subClasses": ["1398"], "name": "diagnostic guideline for probable progressive supranuclear palsy", "body": "", "children": [{"id": "1398", "iri": "1398", "baseIri": "1398", "instances": "1398", "attributes": "1398", "label_IRI-based": "ND_0001136", "label_undefined": "diagnostic guideline for definite progressive supranuclear palsy", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1399"], "subClasses": null, "name": "diagnostic guideline for definite progressive supranuclear palsy", "body": ""}]}]}, {"id": "1340", "iri": "1340", "baseIri": "1340", "instances": "1340", "attributes": "1340", "label_IRI-based": "ND_0001125", "label_undefined": "diagnostic guideline for possible multiple system atrophy", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1404"], "name": "diagnostic guideline for possible multiple system atrophy", "body": "", "children": [{"id": "1404", "iri": "1404", "baseIri": "1404", "instances": "1404", "attributes": "1404", "label_IRI-based": "ND_0001130", "label_undefined": "diagnostic guideline for probable multiple system atrophy", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1340"], "subClasses": ["1403"], "name": "diagnostic guideline for probable multiple system atrophy", "body": "", "children": [{"id": "1403", "iri": "1403", "baseIri": "1403", "instances": "1403", "attributes": "1403", "label_IRI-based": "ND_0001135", "label_undefined": "diagnostic guideline for definite multiple system atrophy", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "*** REVISE ***\n\nA definite diagnosis of multiple system atrophy can only be made post-mortem based on pathology in which abundant glial cytoplasmic inclusions are found in the central nervous system.", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "http://en.wikipedia.org/wiki/Multiple_system_atrophy#Diagnosis", "type": "label"}]}, "superClasses": ["1404"], "subClasses": null, "name": "diagnostic guideline for definite multiple system atrophy", "body": "*** REVISE ***\n\nA definite diagnosis of multiple system atrophy can only be made post-mortem based on pathology in which abundant glial cytoplasmic inclusions are found in the central nervous system."}]}]}, {"id": "1338", "iri": "1338", "baseIri": "1338", "instances": "1338", "attributes": "1338", "label_IRI-based": "ND_0001137", "label_undefined": "diagnostic guideline for possible Alzheimers disease", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "A. The development of multiple cognitive deficits manifested by both \n\n(1) memory impairment (impaired ability to learn new information or to recall previously learned information) \n\n(2) one (or more) of the following cognitive disturbances: \n\n(a) aphasia (language disturbance) \n(b) apraxia (impaired ability to carry out motor activities despite intact motor function) \n(c) agnosia (failure to recognize or identify objects despite intact sensory function) \n(d) disturbance in executive functioning (i.e., planning, organizing, sequencing, abstracting)\n\nB. The cognitive deficits in Criteria A1 and A2 each cause significant impairment in social or occupational functioning and represent a significant decline from a previous level of functioning. \n\nC. The course is characterized by gradual onset and continuing cognitive decline. \n\nD. The cognitive deficits in Criteria A1 and A2 are not due to any of the following: \n\n(1) other central nervous system conditions that cause progressive deficits in memory and cognition (e.g., cerebrovascular disease, Parkinson's disease, Huntington's disease, subdural hematoma, normal-pressure hydrocephalus, brain tumor) \n(2) systemic conditions that are known to cause dementia (e.g., hypothyroidism, vitamin B or folic acid deficiency, niacin deficiency, hypercalcemia, neurosyphilis, HIV infection) \n(3) substance-induced conditions \n\nE. The deficits do not occur exclusively during the course of a delirium. \n\nF. The disturbance is not better accounted for by another Axis I disorder (e.g., Major Depressive Episode, Schizophrenia). \n\n\nDSM IV", "type": "label"}, {"identifier": "IAO_0000115", "language": "undefined", "value": "*** REVISE ***\n\nThere is a dementia syndrome with an atypical onset, presentation or progression; and without a known etiology; but no co-morbid diseases capable of producing dementia are believed to be in the origin of it.\n\nSimilar to the NINCDS-ADRDA Alzheimer's Criteria are the DSM-IV-TR criteria published by the American Psychiatric Association. At the same time the advances in functional neuroimaging techniques such as PET or SPECT that have already proven their utility to differentiate Alzheimer's disease from other possible causes, have led to proposals of revision of the NINCDS-ADRDA criteria that take into account these techniques.", "type": "label"}, {"identifier": "IAO_0000115", "language": "undefined", "value": "I. Probable AD: Core Diagnostic Features\nA. Dementia established by clinical examination (including MMSE, BRDRS, and neuropsychological testing)\nB. Deficit in at least two areas of cognition \ni. Memory (required)\nii. Other area besides memory\nC. Deficits characterized by gradual onset and progression, onset after age 40\nD. Other systemic disorders or brain disease do not account for the progressive deficits in memory and cognition in and of themselves\n\nII. Possible AD: Core Diagnostic Features \n\nA. Dementia syndrome in the absence of other neurologic, psychiatric, or systemic disorder, OR\nB. Presence of a second systemic or brain disorder sufficient to produce dementia, which is not considered to be the primary cause of the dementia\n\nIII. Features that make a diagnosis of Probable or Possible AD unlikely or uncertain\nA. Sudden apoplectic onset\nB. Focal neurologic findings such as hemiparesis, sensory loss, visual field deficits, and incoordination early in the course of the illness\nC. Seizures or gait disturbances at the onset or very early in the course of the illness", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "http://behavenet.com/dementia-alzheimers-type", "type": "label"}, {"identifier": "IAO_0000119", "language": "undefined", "value": "http://en.wikipedia.org/wiki/NINCDS-ADRDA_Alzheimer%27s_Criteria", "type": "label"}, {"identifier": "IAO_0000119", "language": "undefined", "value": "NINCDS-ADRDA Criteria for the Diagnosis of Alzheimer's Disease", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1385"], "name": "diagnostic guideline for possible Alzheimers disease", "body": "I. Probable AD: Core Diagnostic Features\nA. Dementia established by clinical examination (including MMSE, BRDRS, and neuropsychological testing)\nB. Deficit in at least two areas of cognition \ni. Memory (required)\nii. Other area besides memory\nC. Deficits characterized by gradual onset and progression, onset after age 40\nD. Other systemic disorders or brain disease do not account for the progressive deficits in memory and cognition in and of themselves\n\nII. Possible AD: Core Diagnostic Features \n\nA. Dementia syndrome in the absence of other neurologic, psychiatric, or systemic disorder, OR\nB. Presence of a second systemic or brain disorder sufficient to produce dementia, which is not considered to be the primary cause of the dementia\n\nIII. Features that make a diagnosis of Probable or Possible AD unlikely or uncertain\nA. Sudden apoplectic onset\nB. Focal neurologic findings such as hemiparesis, sensory loss, visual field deficits, and incoordination early in the course of the illness\nC. Seizures or gait disturbances at the onset or very early in the course of the illness\n\nA. The development of multiple cognitive deficits manifested by both \n\n(1) memory impairment (impaired ability to learn new information or to recall previously learned information) \n\n(2) one (or more) of the following cognitive disturbances: \n\n(a) aphasia (language disturbance) \n(b) apraxia (impaired ability to carry out motor activities despite intact motor function) \n(c) agnosia (failure to recognize or identify objects despite intact sensory function) \n(d) disturbance in executive functioning (i.e., planning, organizing, sequencing, abstracting)\n\nB. The cognitive deficits in Criteria A1 and A2 each cause significant impairment in social or occupational functioning and represent a significant decline from a previous level of functioning. \n\nC. The course is characterized by gradual onset and continuing cognitive decline. \n\nD. The cognitive deficits in Criteria A1 and A2 are not due to any of the following: \n\n(1) other central nervous system conditions that cause progressive deficits in memory and cognition (e.g., cerebrovascular disease, Parkinson's disease, Huntington's disease, subdural hematoma, normal-pressure hydrocephalus, brain tumor) \n(2) systemic conditions that are known to cause dementia (e.g., hypothyroidism, vitamin B or folic acid deficiency, niacin deficiency, hypercalcemia, neurosyphilis, HIV infection) \n(3) substance-induced conditions \n\nE. The deficits do not occur exclusively during the course of a delirium. \n\nF. The disturbance is not better accounted for by another Axis I disorder (e.g., Major Depressive Episode, Schizophrenia). \n\n\nDSM IV\n\n*** REVISE ***\n\nThere is a dementia syndrome with an atypical onset, presentation or progression; and without a known etiology; but no co-morbid diseases capable of producing dementia are believed to be in the origin of it.\n\nSimilar to the NINCDS-ADRDA Alzheimer's Criteria are the DSM-IV-TR criteria published by the American Psychiatric Association. At the same time the advances in functional neuroimaging techniques such as PET or SPECT that have already proven their utility to differentiate Alzheimer's disease from other possible causes, have led to proposals of revision of the NINCDS-ADRDA criteria that take into account these techniques.", "children": [{"id": "1385", "iri": "1385", "baseIri": "1385", "instances": "1385", "attributes": "1385", "label_IRI-based": "ND_0001139", "label_undefined": "diagnostic guideline for probable Alzheimers disease", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "A. Presence of an early and significant episodic memory impairment that includes the following features:\n\n1. Gradual and progressive change in memory function reported by patients or\ninformants over more than 6 months\n\n2. Objective evidence of significantly impaired episodic memory on testing: this\ngenerally consists of recall deficit that does not improve significantly or does not\nnormalize with cueing or recognition testing and after effective encoding of\ninformation has been previously controlled\n\n3. The episodic memory impairment can be isolated or associated with other cognitive\nchanges at the onset of AD or as AD advances\n\nPlus one or more of the following supportive features B, C, D, and E:\n\nB. Presence of medial temporal lobe atrophy\n\u2022 Volume loss of hippocampi, entorhinal cortex, amygdala evidenced on MRI with\nqualitative ratings using visual scoring (referenced to well characterised population\nwith age norms) or quantitative volumetry of regions of interest (referenced to well\ncharacterised population with age norms)\n\nC. Abnormal cerebrospinal fluid biomarker\n\u2022 Low amyloid \u03b21\u201342 concentrations, increased total tau concentrations, or increased\nphospho-tau concentrations, or combinations of the three\n\u2022 Other well validated markers to be discovered in the future\n\nD. Specific pattern on functional neuroimaging with PET\n\u2022 Reduced glucose metabolism in bilateral temporal parietal regions\n\u2022 Other well validated ligands, including those that foreseeably will emerge such as\nPittsburg compound B or FDDNP\n\nE. Proven AD autosomal dominant mutation within the immediate family\n\nAnd LACKS the following:\n\nHistory\n\u2022 Sudden onset\n\u2022 Early occurrence of the following symptoms: gait disturbances, seizures, behavioural changes\n\nClinical features\n\u2022 Focal neurological features including hemiparesis, sensory loss, visual field deficits\n\u2022 Early extrapyramidal signs \n\u2022 Other medical disorders severe enough to account for memory and related symptoms\n\u2022 Non-AD dementia\n\u2022 Major depression\n\u2022 Cerebrovascular disease\n\u2022 Toxic and metabolic abnormalities, all of which may require specific investigations\n\u2022 MRI FLAIR or T2 signal abnormalities in the medial temporal lobe that are consistent with infectious or vascular insults\n", "type": "label"}, {"identifier": "IAO_0000115", "language": "undefined", "value": "I. Probable AD: Core Diagnostic Features\nA. Dementia established by clinical examination (including MMSE, BRDRS, and neuropsychological testing)\nB. Deficit in at least two areas of cognition \ni. Memory (required)\nii. Other area besides memory\nC. Deficits characterized by gradual onset and progression, onset after age 40\nD. Other systemic disorders or brain disease do not account for the progressive deficits in memory and cognition in and of themselves\n\nII. Features that make a diagnosis of Probable or Possible AD unlikely or uncertain\nA. Sudden apoplectic onset\nB. Focal neurologic findings such as hemiparesis, sensory loss, visual field deficits, and incoordination early in the course of the illness\nC. Seizures or gait disturbances at the onset or very early in the course of the illness", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "NINCDS-ADRDA Criteria for the Diagnosis of Alzheimer's Disease", "type": "label"}]}, "superClasses": ["1338"], "subClasses": ["1431"], "name": "diagnostic guideline for probable Alzheimers disease", "body": "I. Probable AD: Core Diagnostic Features\nA. Dementia established by clinical examination (including MMSE, BRDRS, and neuropsychological testing)\nB. Deficit in at least two areas of cognition \ni. Memory (required)\nii. Other area besides memory\nC. Deficits characterized by gradual onset and progression, onset after age 40\nD. Other systemic disorders or brain disease do not account for the progressive deficits in memory and cognition in and of themselves\n\nII. Features that make a diagnosis of Probable or Possible AD unlikely or uncertain\nA. Sudden apoplectic onset\nB. Focal neurologic findings such as hemiparesis, sensory loss, visual field deficits, and incoordination early in the course of the illness\nC. Seizures or gait disturbances at the onset or very early in the course of the illness\n\nA. Presence of an early and significant episodic memory impairment that includes the following features:\n\n1. Gradual and progressive change in memory function reported by patients or\ninformants over more than 6 months\n\n2. Objective evidence of significantly impaired episodic memory on testing: this\ngenerally consists of recall deficit that does not improve significantly or does not\nnormalize with cueing or recognition testing and after effective encoding of\ninformation has been previously controlled\n\n3. The episodic memory impairment can be isolated or associated with other cognitive\nchanges at the onset of AD or as AD advances\n\nPlus one or more of the following supportive features B, C, D, and E:\n\nB. Presence of medial temporal lobe atrophy\n\u2022 Volume loss of hippocampi, entorhinal cortex, amygdala evidenced on MRI with\nqualitative ratings using visual scoring (referenced to well characterised population\nwith age norms) or quantitative volumetry of regions of interest (referenced to well\ncharacterised population with age norms)\n\nC. Abnormal cerebrospinal fluid biomarker\n\u2022 Low amyloid \u03b21\u201342 concentrations, increased total tau concentrations, or increased\nphospho-tau concentrations, or combinations of the three\n\u2022 Other well validated markers to be discovered in the future\n\nD. Specific pattern on functional neuroimaging with PET\n\u2022 Reduced glucose metabolism in bilateral temporal parietal regions\n\u2022 Other well validated ligands, including those that foreseeably will emerge such as\nPittsburg compound B or FDDNP\n\nE. Proven AD autosomal dominant mutation within the immediate family\n\nAnd LACKS the following:\n\nHistory\n\u2022 Sudden onset\n\u2022 Early occurrence of the following symptoms: gait disturbances, seizures, behavioural changes\n\nClinical features\n\u2022 Focal neurological features including hemiparesis, sensory loss, visual field deficits\n\u2022 Early extrapyramidal signs \n\u2022 Other medical disorders severe enough to account for memory and related symptoms\n\u2022 Non-AD dementia\n\u2022 Major depression\n\u2022 Cerebrovascular disease\n\u2022 Toxic and metabolic abnormalities, all of which may require specific investigations\n\u2022 MRI FLAIR or T2 signal abnormalities in the medial temporal lobe that are consistent with infectious or vascular insults\n", "children": [{"id": "1431", "iri": "1431", "baseIri": "1431", "instances": "1431", "attributes": "1431", "label_IRI-based": "ND_0001149", "label_undefined": "diagnostic guideline for definite Alzheimers disease", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "*** REVISE ***\n\nThe patient meets the criteria for probable Alzheimer's disease and has either:\n1. Both clinical and histopathological (brain biopsy or autopsy) evidence of the disease, as required by the NIA-Reagan criteria for the post-mortem diagnosis of alzheimers disease \nor\n2. Both clinical and genetic evidence (mutation on chromosome 1, 14, or 21) of alzheimers disease ", "type": "label"}, {"identifier": "IAO_0000115", "language": "undefined", "value": "I. Probable AD: Core Diagnostic Features\nA. Dementia established by clinical examination (including MMSE, BRDRS, and neuropsychological testing)\nB. Deficit in at least two areas of cognition \ni. Memory (required)\nii. Other area besides memory\nC. Deficits characterized by gradual onset and progression, onset after age 40\nD. Other systemic disorders or brain disease do not account for the progressive deficits in memory and cognition in and of themselves\n\nII. Possible AD: Core Diagnostic Features \n\nA. Dementia syndrome in the absence of other neurologic, psychiatric, or systemic disorder, OR\nB. Presence of a second systemic or brain disorder sufficient to produce dementia, which is not considered to be the primary cause of the dementia\n\nIII. Features that make a diagnosis of Probable or Possible AD unlikely or uncertain\nA. Sudden apoplectic onset\nB. Focal neurologic findings such as hemiparesis, sensory loss, visual field deficits, and incoordination early in the course of the illness\nC. Seizures or gait disturbances at the onset or very early in the course of the illness\n\nIV. Criteria for diagnosis of Definite Alzheimer's disease: \nA. Clinical criteria for probable Alzheimer's disease\nB. Histopathologic evidence obtained from a biopsy or autopsy\n\nAs AD progresses, patients frequently suffer from neuropsychiatric complications such as agitation, apathy, delusions, hallucinations or depression. In many cases, these constitute a greater burden for caregivers than the cognitive deficits and may require treatment with psychoactive medications.", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "NINCDS-ADRDA Criteria for the Diagnosis of Alzheimer's Disease", "type": "label"}, {"identifier": "IAO_0000119", "language": "undefined", "value": "Adapted from: http://en.wikipedia.org/wiki/NINCDS-ADRDA_Alzheimer%27s_Criteria", "type": "label"}]}, "superClasses": ["1385"], "subClasses": null, "name": "diagnostic guideline for definite Alzheimers disease", "body": "I. Probable AD: Core Diagnostic Features\nA. Dementia established by clinical examination (including MMSE, BRDRS, and neuropsychological testing)\nB. Deficit in at least two areas of cognition \ni. Memory (required)\nii. Other area besides memory\nC. Deficits characterized by gradual onset and progression, onset after age 40\nD. Other systemic disorders or brain disease do not account for the progressive deficits in memory and cognition in and of themselves\n\nII. Possible AD: Core Diagnostic Features \n\nA. Dementia syndrome in the absence of other neurologic, psychiatric, or systemic disorder, OR\nB. Presence of a second systemic or brain disorder sufficient to produce dementia, which is not considered to be the primary cause of the dementia\n\nIII. Features that make a diagnosis of Probable or Possible AD unlikely or uncertain\nA. Sudden apoplectic onset\nB. Focal neurologic findings such as hemiparesis, sensory loss, visual field deficits, and incoordination early in the course of the illness\nC. Seizures or gait disturbances at the onset or very early in the course of the illness\n\nIV. Criteria for diagnosis of Definite Alzheimer's disease: \nA. Clinical criteria for probable Alzheimer's disease\nB. Histopathologic evidence obtained from a biopsy or autopsy\n\nAs AD progresses, patients frequently suffer from neuropsychiatric complications such as agitation, apathy, delusions, hallucinations or depression. In many cases, these constitute a greater burden for caregivers than the cognitive deficits and may require treatment with psychoactive medications.\n\n*** REVISE ***\n\nThe patient meets the criteria for probable Alzheimer's disease and has either:\n1. Both clinical and histopathological (brain biopsy or autopsy) evidence of the disease, as required by the NIA-Reagan criteria for the post-mortem diagnosis of alzheimers disease \nor\n2. Both clinical and genetic evidence (mutation on chromosome 1, 14, or 21) of alzheimers disease "}]}]}, {"id": "28", "iri": "28", "baseIri": "28", "instances": "28", "attributes": "28", "label_IRI-based": "ND_0001138", "label_undefined": "diagnostic guideline for possible atypical Alzheimers disease", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1180"], "name": "diagnostic guideline for possible atypical Alzheimers disease", "body": "", "children": [{"id": "1180", "iri": "1180", "baseIri": "1180", "instances": "1180", "attributes": "1180", "label_IRI-based": "ND_0001144", "label_undefined": "diagnostic guideline for probable atypical Alzheimers disease", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["28"], "subClasses": ["1179"], "name": "diagnostic guideline for probable atypical Alzheimers disease", "body": "", "children": [{"id": "1179", "iri": "1179", "baseIri": "1179", "instances": "1179", "attributes": "1179", "label_IRI-based": "ND_0001150", "label_undefined": "diagnostic guideline for definite atypical Alzheimers disease", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1180"], "subClasses": null, "name": "diagnostic guideline for definite atypical Alzheimers disease", "body": ""}]}]}, {"id": "1150", "iri": "1150", "baseIri": "1150", "instances": "1150", "attributes": "1150", "label_IRI-based": "ND_0001143", "label_undefined": "diagnostic guideline for possible primary progressive non-fluent aphasia", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1149"], "name": "diagnostic guideline for possible primary progressive non-fluent aphasia", "body": "", "children": [{"id": "1149", "iri": "1149", "baseIri": "1149", "instances": "1149", "attributes": "1149", "label_IRI-based": "ND_0001148", "label_undefined": "diagnostic guideline for probable primary progressive non-fluent aphasia", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1150"], "subClasses": ["1199"], "name": "diagnostic guideline for probable primary progressive non-fluent aphasia", "body": "", "children": [{"id": "1199", "iri": "1199", "baseIri": "1199", "instances": "1199", "attributes": "1199", "label_IRI-based": "ND_0001154", "label_undefined": "diagnostic guideline for definite primary progressive non-fluent aphasia", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "At least one of the core features (1 and 2) must be present, and at least two of the following other features (3-5) must be present.\nAgrammatism in language production\nEffortful, halting speech with inconsistent distortions, deletions, substitutions, insertions, or transpositions of speech sounds, particularly in polysyllabic words (often considered to reflect \"apraxia of speech\")\nImpaired comprehension of syntactically complex sentences\nSpared single word comprehension\nSpared object knowledge\nImaging-Supported NFAV-PPA Diagnosis\nBoth of the following criteria must be present.\nClinical diagnosis of NFAV-PPA\nImaging must show one or more of the following results:\nPredominant left posterior fronto-insular atrophy on MRI\nPredominant left posterior fronto-insular hypoperfusion or hypometabolism on SPECT or PET", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "http://memory.ucsf.edu/ftd/medical/diagnosis/criteria/single", "type": "label"}]}, "superClasses": ["1149"], "subClasses": null, "name": "diagnostic guideline for definite primary progressive non-fluent aphasia", "body": "At least one of the core features (1 and 2) must be present, and at least two of the following other features (3-5) must be present.\nAgrammatism in language production\nEffortful, halting speech with inconsistent distortions, deletions, substitutions, insertions, or transpositions of speech sounds, particularly in polysyllabic words (often considered to reflect \"apraxia of speech\")\nImpaired comprehension of syntactically complex sentences\nSpared single word comprehension\nSpared object knowledge\nImaging-Supported NFAV-PPA Diagnosis\nBoth of the following criteria must be present.\nClinical diagnosis of NFAV-PPA\nImaging must show one or more of the following results:\nPredominant left posterior fronto-insular atrophy on MRI\nPredominant left posterior fronto-insular hypoperfusion or hypometabolism on SPECT or PET"}]}]}, {"id": "1154", "iri": "1154", "baseIri": "1154", "instances": "1154", "attributes": "1154", "label_IRI-based": "ND_0001142", "label_undefined": "diagnostic guideline for possible posterior cortical atrophy", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1153"], "name": "diagnostic guideline for possible posterior cortical atrophy", "body": "", "children": [{"id": "1153", "iri": "1153", "baseIri": "1153", "instances": "1153", "attributes": "1153", "label_IRI-based": "ND_0001147", "label_undefined": "diagnostic guideline for probable posterior cortical atrophy", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1154"], "subClasses": ["1201"], "name": "diagnostic guideline for probable posterior cortical atrophy", "body": "", "children": [{"id": "1201", "iri": "1201", "baseIri": "1201", "instances": "1201", "attributes": "1201", "label_IRI-based": "ND_0001153", "label_undefined": "diagnostic guideline for definite posterior cortical atrophy", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1153"], "subClasses": null, "name": "diagnostic guideline for definite posterior cortical atrophy", "body": ""}]}]}, {"id": "1158", "iri": "1158", "baseIri": "1158", "instances": "1158", "attributes": "1158", "label_IRI-based": "ND_0001141", "label_undefined": "diagnostic guideline for possible logopenic aphasia", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1157"], "name": "diagnostic guideline for possible logopenic aphasia", "body": "", "children": [{"id": "1157", "iri": "1157", "baseIri": "1157", "instances": "1157", "attributes": "1157", "label_IRI-based": "ND_0001146", "label_undefined": "diagnostic guideline for probable logopenic aphasia", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1158"], "subClasses": ["1171"], "name": "diagnostic guideline for probable logopenic aphasia", "body": "", "children": [{"id": "1171", "iri": "1171", "baseIri": "1171", "instances": "1171", "attributes": "1171", "label_IRI-based": "ND_0001152", "label_undefined": "diagnostic guideline for definite logopenic aphasia", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1157"], "subClasses": null, "name": "diagnostic guideline for definite logopenic aphasia", "body": ""}]}]}, {"id": "1163", "iri": "1163", "baseIri": "1163", "instances": "1163", "attributes": "1163", "label_IRI-based": "ND_0001140", "label_undefined": "diagnostic guideline for possible frontal variant of Alzheimers disease", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "Possible bvFTD\nThree of the following behavioral/cognitive symptoms must be present to meet criteria. These symptoms should occur repeatedly, not just as a single instance.\nEarly behavioral disinhibition (one of the following must be present)\nSocially inappropriate behavior: touching or kissing strangers, inappropriate sexual acts, public urination, criminal behavior, etc.\nLoss of manners or decorum: examples include\ncrude or sexually explicit remarks, jokes or opinions which may be offensive to others;\nlack of response to social cues (e.g., will continue talking despite other\u2019s attempts to end a conversation);\nphysical behaviors such as flatulence, touching private body parts, belching or spitting;\npoor hygiene or grooming (malodorous, stained, torn or inappropriate clothing),\nloss of respect for interpersonal space\nImpulsive, rash or careless actions: impulsive behaviors which may or may not be performed in a social context (e.g., new- onset gambling, taking things, stealing (usually food or visually stimulating objects), buying or selling property without regard for consequences)\nEarly apathy or inertia (one of the following must be present)\nApathy: loss of interest, drive or motivation (e.g., passivity, lack of spontaneity, does not engage in previously rewarding activities)\nInertia: decreased initiation of behavior (e.g., needs prompting to initiate or continue routine activities, less likely to initiate or sustain conversations)\nEarly loss of sympathy or empathy (one of the following must be present)\nDiminished response to other people\u2019s needs and feelings: positive rating of this feature should be based on specific examples that reflect a lack of understanding or indifference to other people\u2019s feelings \u2013 e.g., hurtful comments, disregard for other\u2019s pain or distress, making inappropriate jokes\nDiminished social interest, interrelatedness or personal warmth: general decrease in social engagement (coldness, lack of eye contact, etc.)\nEarly perseverative, stereotyped or compulsive/ritualistic behavior (one of the following must be present)\nSimple repetitive movements: tapping, clapping, rubbing, scratching, picking at skin or clothing, pursing lips, lip smacking, etc.\nComplex, compulsive or ritualistic behaviors: counting and cleaning rituals, collecting, checking, repetitive trips to the bathroom, ordering objects, walking fixed routes, etc.\nStereotypy of speech: repeating words or phrases that have no communicative value\nHyperorality and dietary changes (one of the following must be present)\nAltered food preferences: carbohydrate craving (particularly sweets) or food fads\nBinge eating, increased consumption of alcohol or cigarettes: patient continues to eat despite satiety (weight gain ____ lb); compulsive smoking, chewing tobacco or gum; or alcohol ingestion\nOral exploration or consumption of inedible objects\nNeuropsychological profile: executive/generation deficits with relative sparing of memory and visuospatial functions (all of the following must be present)\nDeficits in executive tasks: Trails-B, generation tasks (letter fluency/design fluency) or presence of errors (e.g., perseverations or rule violations)\nRelative sparing of episodic memory\nRelative sparing of visuospatial skills e.g., ability to copy simple line drawings\nExclusion Criteria for bvFTD\nCriteria 1 and 2 must both be answered negatively for any bvFTD diagnosis. Criterion 3 can be positive for possible bvFTD but must be negative for probable bvFTD.\nPattern of deficits is better accounted for by other non-degenerative nervous system or medical disorders (excludes all bvFTD diagnoses) e.g., delirium, cerebrovascular disease, cerebellar disorder, systemic disorders (e.g., hypothyroidism) or substance-induced conditions\nBehavioral disturbance is better accounted for by a psychiatric diagnosis (excludes all bvFTD diagnoses) e.g., depression, bipolar disorder, schizophrenia, pre-existing personality disorder\nBiomarkers strongly indicative of Alzheimer\u2019s disease or other neurodegenerative process (excludes diagnosis of probable bvFTD) e.g., genetic mutations, extensive PIB binding, CSF markers", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "http://memory.ucsf.edu/ftd/medical/diagnosis/criteria/single", "type": "label"}]}, "superClasses": ["15"], "subClasses": ["1162"], "name": "diagnostic guideline for possible frontal variant of Alzheimers disease", "body": "Possible bvFTD\nThree of the following behavioral/cognitive symptoms must be present to meet criteria. These symptoms should occur repeatedly, not just as a single instance.\nEarly behavioral disinhibition (one of the following must be present)\nSocially inappropriate behavior: touching or kissing strangers, inappropriate sexual acts, public urination, criminal behavior, etc.\nLoss of manners or decorum: examples include\ncrude or sexually explicit remarks, jokes or opinions which may be offensive to others;\nlack of response to social cues (e.g., will continue talking despite other\u2019s attempts to end a conversation);\nphysical behaviors such as flatulence, touching private body parts, belching or spitting;\npoor hygiene or grooming (malodorous, stained, torn or inappropriate clothing),\nloss of respect for interpersonal space\nImpulsive, rash or careless actions: impulsive behaviors which may or may not be performed in a social context (e.g., new- onset gambling, taking things, stealing (usually food or visually stimulating objects), buying or selling property without regard for consequences)\nEarly apathy or inertia (one of the following must be present)\nApathy: loss of interest, drive or motivation (e.g., passivity, lack of spontaneity, does not engage in previously rewarding activities)\nInertia: decreased initiation of behavior (e.g., needs prompting to initiate or continue routine activities, less likely to initiate or sustain conversations)\nEarly loss of sympathy or empathy (one of the following must be present)\nDiminished response to other people\u2019s needs and feelings: positive rating of this feature should be based on specific examples that reflect a lack of understanding or indifference to other people\u2019s feelings \u2013 e.g., hurtful comments, disregard for other\u2019s pain or distress, making inappropriate jokes\nDiminished social interest, interrelatedness or personal warmth: general decrease in social engagement (coldness, lack of eye contact, etc.)\nEarly perseverative, stereotyped or compulsive/ritualistic behavior (one of the following must be present)\nSimple repetitive movements: tapping, clapping, rubbing, scratching, picking at skin or clothing, pursing lips, lip smacking, etc.\nComplex, compulsive or ritualistic behaviors: counting and cleaning rituals, collecting, checking, repetitive trips to the bathroom, ordering objects, walking fixed routes, etc.\nStereotypy of speech: repeating words or phrases that have no communicative value\nHyperorality and dietary changes (one of the following must be present)\nAltered food preferences: carbohydrate craving (particularly sweets) or food fads\nBinge eating, increased consumption of alcohol or cigarettes: patient continues to eat despite satiety (weight gain ____ lb); compulsive smoking, chewing tobacco or gum; or alcohol ingestion\nOral exploration or consumption of inedible objects\nNeuropsychological profile: executive/generation deficits with relative sparing of memory and visuospatial functions (all of the following must be present)\nDeficits in executive tasks: Trails-B, generation tasks (letter fluency/design fluency) or presence of errors (e.g., perseverations or rule violations)\nRelative sparing of episodic memory\nRelative sparing of visuospatial skills e.g., ability to copy simple line drawings\nExclusion Criteria for bvFTD\nCriteria 1 and 2 must both be answered negatively for any bvFTD diagnosis. Criterion 3 can be positive for possible bvFTD but must be negative for probable bvFTD.\nPattern of deficits is better accounted for by other non-degenerative nervous system or medical disorders (excludes all bvFTD diagnoses) e.g., delirium, cerebrovascular disease, cerebellar disorder, systemic disorders (e.g., hypothyroidism) or substance-induced conditions\nBehavioral disturbance is better accounted for by a psychiatric diagnosis (excludes all bvFTD diagnoses) e.g., depression, bipolar disorder, schizophrenia, pre-existing personality disorder\nBiomarkers strongly indicative of Alzheimer\u2019s disease or other neurodegenerative process (excludes diagnosis of probable bvFTD) e.g., genetic mutations, extensive PIB binding, CSF markers", "children": [{"id": "1162", "iri": "1162", "baseIri": "1162", "instances": "1162", "attributes": "1162", "label_IRI-based": "ND_0001145", "label_undefined": "diagnostic guideline for probable frontal variant of Alzheimers disease", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1163"], "subClasses": ["1175"], "name": "diagnostic guideline for probable frontal variant of Alzheimers disease", "body": "", "children": [{"id": "1175", "iri": "1175", "baseIri": "1175", "instances": "1175", "attributes": "1175", "label_IRI-based": "ND_0001151", "label_undefined": "diagnostic guideline for definite frontal variant of Alzheimers disease", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1162"], "subClasses": null, "name": "diagnostic guideline for definite frontal variant of Alzheimers disease", "body": ""}]}]}]}, {"id": "1318", "iri": "1318", "baseIri": "1318", "instances": "1318", "attributes": "1318", "label_IRI-based": "ND_0001104", "label_undefined": "diagnostic guideline for vascular dementia", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "A. The development of multiple cognitive deficits manifested by both:\n\nMemory impairment (impaired ability to learn new information or to recall previously learned information)\nOne or more of the following cognitive disturbances:\n(a) aphasia (language disturbance)\n\n(b) apraxia (impaired ability to carry out motor activities depite intact motor function)\n\n(c) agnosia (failure to recognize or identify objects despite intact sensory function)\n\n(d) disturbance in executive functioning (i.e., planning, organizing, sequencing, abstracting)\nB. The cognitive deficits in criteria A1 and A2 each cause significant impairment in social or occupational functioning and represent a significant decline from a previous level of functioning.\n\nC. Focal neurological signs and symptoms (e.g., exggeration of deep tendon reflexes, extensor plantar response, psuedobulbar palsy, gait abnormalities, weakness of an extremity) or laboratory evidence indicative of cerebrovascular disease (e.g., multiple infarctions involving cortex and underlyig white matter) that are judged to be etiologically related to the disturbance.\n\nD. The deficits do not ocurr exclusively during the course of a delirium.", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "http://www.strokecenter.org/professionals/stroke-diagnosis/stroke-assessment-scales/dsm-iv-criteria-for-the-diagnosis-of-vascular-dementia/", "type": "label"}]}, "superClasses": ["1329"], "subClasses": ["1317"], "name": "diagnostic guideline for vascular dementia", "body": "A. The development of multiple cognitive deficits manifested by both:\n\nMemory impairment (impaired ability to learn new information or to recall previously learned information)\nOne or more of the following cognitive disturbances:\n(a) aphasia (language disturbance)\n\n(b) apraxia (impaired ability to carry out motor activities depite intact motor function)\n\n(c) agnosia (failure to recognize or identify objects despite intact sensory function)\n\n(d) disturbance in executive functioning (i.e., planning, organizing, sequencing, abstracting)\nB. The cognitive deficits in criteria A1 and A2 each cause significant impairment in social or occupational functioning and represent a significant decline from a previous level of functioning.\n\nC. Focal neurological signs and symptoms (e.g., exggeration of deep tendon reflexes, extensor plantar response, psuedobulbar palsy, gait abnormalities, weakness of an extremity) or laboratory evidence indicative of cerebrovascular disease (e.g., multiple infarctions involving cortex and underlyig white matter) that are judged to be etiologically related to the disturbance.\n\nD. The deficits do not ocurr exclusively during the course of a delirium.", "children": [{"id": "1317", "iri": "1317", "baseIri": "1317", "instances": "1317", "attributes": "1317", "label_IRI-based": "ND_0001110", "label_undefined": "diagnostic guideline for possible ischemic vascular dementia", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "*** REVISE ***\n\nDementia with no other cause plus focal signs without imaging findings or no clear temporal relationship.", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1318"], "subClasses": ["1441"], "name": "diagnostic guideline for possible ischemic vascular dementia", "body": "*** REVISE ***\n\nDementia with no other cause plus focal signs without imaging findings or no clear temporal relationship.", "children": [{"id": "1441", "iri": "1441", "baseIri": "1441", "instances": "1441", "attributes": "1441", "label_IRI-based": "ND_0001111", "label_undefined": "diagnostic guideline for probable ischemic vascular dementia", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "*** REVISE ***\n\nDementia with no other cause plus evidence of CVD by history, examination or imaging and a relationship between onset or progression of dementia (onset within 3 months or stepwise course).", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1317"], "subClasses": ["1440"], "name": "diagnostic guideline for probable ischemic vascular dementia", "body": "*** REVISE ***\n\nDementia with no other cause plus evidence of CVD by history, examination or imaging and a relationship between onset or progression of dementia (onset within 3 months or stepwise course).", "children": [{"id": "1440", "iri": "1440", "baseIri": "1440", "instances": "1440", "attributes": "1440", "label_IRI-based": "ND_0001112", "label_undefined": "diagnostic guideline for definite ischemic vascular dementia", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1441"], "subClasses": null, "name": "diagnostic guideline for definite ischemic vascular dementia", "body": ""}]}]}]}]}]}, {"id": "1334", "iri": "1334", "baseIri": "1334", "instances": "1334", "attributes": "1334", "label_IRI-based": "ND_0001113", "label_undefined": "diagnostic guideline for possible normal pressure hydrocephalus", "annotations": {"definition": [{"identifier": "IAO_0000115", "language": "undefined", "value": "*** REVISE ***\n\nDiagnosis of NPH is usually first led by a lumbar puncture, followed by the evaluation of clinical response to removal of CSF. This can be followed by a CT, MRI, and continuous external lumbar CSF drainage during 3 or 4 days.\n\n    Lumbar puncture is usually the first step in diagnosis and the CSF opening pressure is measured carefully. In most cases, CSF pressure is usually above 155 mmH2O. Clinical improvement after removal of CSF (30 mL or more) has a high predictive value for subsequent success with shunting. This is called the \"lumbar tap test\" or Miller Fisher test. On the contrary, a \"negative\" test has a very low predictive accuracy, as many patients may improve after a shunt in spite of lack of improvement after CSF removal.\n\n    Infusion test is a test with higher sensitivity and specificity than a lumbar puncture. The outflow conductance (Cout) of the cerebrospinal fluid (CSF) system is a parameter considered to be predictive in selection for hydrocephalus surgery. Cout can be determined through an infusion test.\n\n    In some centers, External lumbar drainage has been shown to have the highest sensitivity and specificity with regards to predicting a successful outcome following surgery.\n\n    CT scan may show enlarged ventricles without convolutional atrophy.\n\n    MRI may show some degree of transependymal migration of CSF surrounding the ventricles on T2/FLAIR sequence. Imaging however cannot differentiate between pathologies with similar clinical picture like Alzheimer's dementia, vascular dementia or Parkinson's disease.", "type": "label"}], "term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "http://en.wikipedia.org/wiki/Normal_pressure_hydrocephalus#Diagnosis", "type": "label"}]}, "superClasses": ["66"], "subClasses": ["1285"], "name": "diagnostic guideline for possible normal pressure hydrocephalus", "body": "*** REVISE ***\n\nDiagnosis of NPH is usually first led by a lumbar puncture, followed by the evaluation of clinical response to removal of CSF. This can be followed by a CT, MRI, and continuous external lumbar CSF drainage during 3 or 4 days.\n\n    Lumbar puncture is usually the first step in diagnosis and the CSF opening pressure is measured carefully. In most cases, CSF pressure is usually above 155 mmH2O. Clinical improvement after removal of CSF (30 mL or more) has a high predictive value for subsequent success with shunting. This is called the \"lumbar tap test\" or Miller Fisher test. On the contrary, a \"negative\" test has a very low predictive accuracy, as many patients may improve after a shunt in spite of lack of improvement after CSF removal.\n\n    Infusion test is a test with higher sensitivity and specificity than a lumbar puncture. The outflow conductance (Cout) of the cerebrospinal fluid (CSF) system is a parameter considered to be predictive in selection for hydrocephalus surgery. Cout can be determined through an infusion test.\n\n    In some centers, External lumbar drainage has been shown to have the highest sensitivity and specificity with regards to predicting a successful outcome following surgery.\n\n    CT scan may show enlarged ventricles without convolutional atrophy.\n\n    MRI may show some degree of transependymal migration of CSF surrounding the ventricles on T2/FLAIR sequence. Imaging however cannot differentiate between pathologies with similar clinical picture like Alzheimer's dementia, vascular dementia or Parkinson's disease.", "children": [{"id": "1285", "iri": "1285", "baseIri": "1285", "instances": "1285", "attributes": "1285", "label_IRI-based": "ND_0001114", "label_undefined": "diagnostic guideline for probable normal pressure hydrocephalus", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1334"], "subClasses": ["1284"], "name": "diagnostic guideline for probable normal pressure hydrocephalus", "body": "", "children": [{"id": "1284", "iri": "1284", "baseIri": "1284", "instances": "1284", "attributes": "1284", "label_IRI-based": "ND_0001115", "label_undefined": "diagnostic guideline for definite normal pressure hydrocephalus", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Alexander P. Cox", "type": "label"}]}, "superClasses": ["1285"], "subClasses": null, "name": "diagnostic guideline for definite normal pressure hydrocephalus", "body": ""}]}]}, {"id": "1298", "iri": "1298", "baseIri": "1298", "instances": "1298", "attributes": "1298", "label_IRI-based": "ND_0001155", "label_undefined": "diagnostic guideline for diagnosing multiple sclerosis according to McDonald criteria", "annotations": {"term editor": [{"identifier": "IAO_0000117", "language": "undefined", "value": "Mark Jensen", "type": "label"}], "definition source": [{"identifier": "IAO_0000119", "language": "undefined", "value": "http://www.msdiagnosed.org/McDonald.pdf", "type": "label"}]}, "superClasses": ["66"], "subClasses": null, "name": "diagnostic guideline for diagnosing multiple sclerosis according to McDonald criteria", "body": ""}]}